使用依替巴肽进行冠状动脉支架置入术后出现急性严重血小板减少症。
Acute profound thrombocytopenia after use of eptifibatide for coronary stenting.
作者信息
Salengro Emmanuel, Mulvihill Niall T, Farah Bruno
机构信息
Unité de Cardiologie Interventionelle, Clinique Pasteur, Toulouse, France.
出版信息
Catheter Cardiovasc Interv. 2003 Jan;58(1):73-5. doi: 10.1002/ccd.10390.
PMID:12508201
Abstract
This is a case report of a patient who developed profound thrombocytopenia during treatment with eptifibatide after PCI of the mid right coronary artery.
摘要
这是一例右冠状动脉中段经皮冠状动脉介入治疗（PCI）后使用依替巴肽治疗期间发生严重血小板减少症患者的病例报告。
Zotero 插件